Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Single and Multiple Ascending Oral Doses of Avenanthramide — Stella

Home/Inflammation/Single and Multiple Ascending Oral Doses of Avenanthramide

View on ClinicalTrials.gov

Recruiting

Back to Inflammation trials

Single and Multiple Ascending Oral Doses of Avenanthramide

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Canada

Montreal Heart Institute, Montreal, Quebec

Key details

Phase

Early testing / Safety & dosing

Sponsor

Montreal Heart Institute

Collaborators

Ceapro Inc., The Montreal Health Innovations Coordinating Center (MHICC)

Enrollment target

~96 participants

Started

December 2023

Primary completion

June 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 60 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.